In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RTI diversifies into non-biologics ortho

This article was originally published in Clinica

Executive Summary

Biological implant specialist RTI Biologics is moving into metal and synthetic implants by agreeing to acquire Pioneer Surgical Technology for $130 million in cash. As well as expanding RTI’s portfolio, the deal will also help it grow its direct distribution network in both the US and abroad. RTI (Alachua, Florida) believes these additional sales channels will help with the launch of its map3 cellular allogenic bone graft, due later this year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100496

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel